RBC Capital lowers Nike stock price target on China headwinds By Investing.com

RBC Capital cut Nike's price target to $70 from $78 and reduced fiscal 2027 EPS estimates by 15%; NKE trades at $44.63, down 44% from its 52-week high of $80.17 and roughly -30% over the past year. Multiple other brokers trimmed targets (Guggenheim $74, Piper Sandler $60, Evercore ISI $57, Williams Trading $57, BNP Paribas Exane $23), reflecting a weaker outlook driven by Greater China, Converse and Sportswear segment challenges. RBC expects earnings trajectory improvement beginning in Q2 fiscal 2027 but extends Win Now actions through 2026, indicating a prolonged recovery timeline.

Analysis

Nike’s current weakness amplifies two predictable but underpriced transmission channels: inventory digestion at global wholesalers and order smoothing at Asia-based cut-and-sew suppliers. If wholesale partners accelerate markdowning, gross margins for the brand and for smaller retail partners will be hit in the next 2–4 quarters, while contract manufacturers will see 10–20% pulldowns in near-term revenue before any recovery in reorders.

A shift toward defensive cash-conservation (fewer marketing initiatives, tighter promotional cadence, and leaner wholesale exposure) would compress near-term top-line growth but improve free-cash-flow conversion within 6–18 months — a trade-off that benefits financially strong competitors and platform retailers able to buy inventory cheaply. Conversely, a faster-than-expected stabilization in core Asian demand or a successful assortment reset could re-lever margins and produce outsized EPS beats within one fiscal year, making operational cadence the key catalyst to watch.

This is a classic tactical reallocation moment: rotate out of cyclicality into secular growth exposures with asymmetric upside and lower correlation to consumer cyclicality. Monitor weekly sales prints, inventory-to-sales and gross-margin cadence from the next two quarterly reports; those three datapoints will drive the majority of P&L surprises in the coming 3–12 months.

Key Decisions for Investors

• Short NKE via a limited-risk put spread: buy a 12-month put 30% OTM and finance by selling a 12-month put 55% OTM, size 1–2% NAV. Rationale: captures 25–40% downside scenarios while capping premium; target 2.5–4x payoff if weakness persists across two quarterly prints.
• Pair trade — short NKE / long SMCI (equal notional, 6–12 month horizon): size net 1–2% NAV. Rationale: move exposure from a consumer-cyclically levered name into a secular AI/server beneficiary; expect positive carry if consumer sales disappoint while enterprise AI demand remains intact.
• Long SMCI via 9–12 month call spread (buy deeper ITM calls, sell further OTM calls) size 1% NAV. Rationale: asymmetric upside to secular demand for specialized compute with limited capital at risk; set stop if relative performance vs peers falls by 15% in 6 weeks.
• If already long consumer discretionary exposure, buy tail protection on NKE-sized positions: 6–9 month puts 25% OTM sized to cap downside to 3–5% NAV. Rationale: cheap insurance against a faster-than-expected destocking cycle that would widen retail write-downs.
• Monitor catalysts and scale: increase short or protection if sequential inventory-to-sales worsens or if commentary indicates extending aggressive promotional support beyond next quarter; trim shorts if management delivers clear margin re-leverage signals across two consecutive quarters.